ALSTON & BIRD LLP for NOVO NORDISK INC.
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report (this page) | Oct 21, 2019 | $60,000 | Replaced |
| 3rd Quarter - Amendment | Nov 8, 2019 | $60,000 | Yes |
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Implementation of Pub. L. 115-97 (H.R. 1, Tax Cuts and Jobs Act).
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARK RAYDER | — |
Health Issues HCR
General diabetes prevention; medication affordability and access; S. 1948/H.R. 3709, Chronic Disease Management Act; issues related to high deductible health plan pre-deductible coverage of treatments and services for chronic diseases.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PETER J ECKRICH | — |
| JOYCE E GRESKO | — |
| ELINOR HILLER | Senior Advisor, Office of the Administrator, CMS; Director, Medicare Parts C and D Analysis Group, Office of Legislation, CMS. |
| MICHAEL PARK | — |
| EARL POMEROY | — |
| MARK RAYDER | — |
| EMILY A SHAW New | — |
| ROBERT SIGGINS | — |
| MARILYN K YAGER | — |
Medicare/Medicaid MMM
H.R. 1530/S. 595 Treat and Reduce Obesity Act; Medicare Diabetes Prevention Program; Issues related to Medicare Part D; Issues related to International Pricing Index (IPI)/reference pricing in Medicare; H.R. 107 - related to maximum Medicaid rebates; Medicare Part D Rebate Rule; H.R.3 Lower Drug Costs Now Act of 2019.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PETER J ECKRICH | — |
| ELINOR HILLER | Senior Advisor, Office of the Administrator, CMS; Director, Medicare Parts C and D Analysis Group, Office of Legislation, CMS. |
| EARL POMEROY | — |
| MARK RAYDER | — |
| EMILY A SHAW New | — |
| ROBERT SIGGINS | — |
| MARILYN K YAGER | — |
Budget/Appropriations BUD
Issues related to the scoring of Preventive Health Savings Act, H.R. 2584/S. 1361.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PETER J ECKRICH | — |
| JOYCE E GRESKO | — |
| ELINOR HILLER | Senior Advisor, Office of the Administrator, CMS; Director, Medicare Parts C and D Analysis Group, Office of Legislation, CMS. |
| EARL POMEROY | — |
| MARK RAYDER | — |
| EMILY A SHAW New | — |
| ROBERT SIGGINS | — |
| MARILYN K YAGER | — |
Pharmacy PHA
H.R. 1520 - Purple Book Continuity Act of 2019; H.R. 1503 - Orange Book Transparency Act of 2019; Issues related to importation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELINOR HILLER New | Senior Advisor, Office of the Administrator, CMS; Director, Medicare Parts C and D Analysis Group, Office of Legislation, CMS. |
| MARK RAYDER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.